| | RAD51D, RAD51L3-RFFL (R300* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (M292V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G265R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (R239W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R232* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +5 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (M227T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (T97fs +2 more) | Duplication (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (S207L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R186* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (Q160* +1 more) | Single nucleotide variant (nonsense +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (Q151* +1 more) | Single nucleotide variant (nonsense +2 more) | Hereditary breast ovarian cancer syndrome +3 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (R145H +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (L109F +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (R108C) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (D90G) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (Y72fs) | Deletion (frameshift variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (T27K) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | LOC130060715, RAD51D
+2 more | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |